Poland· PL-100357851
Dacepton
A apomorphine product containing apomorphini hydrochloridum hemihydricum, registered in Poland by Ever Neuro Pharma GmbH. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Apomorphine is registered in 10 of 19 countries.
Countries holding a registration under ATC N04BC07 (apomorphine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Apomorphine · ATC N04BC07
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of apomorphine costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Apomorphine · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$18.87
The record
At a glance
URPL (Poland)- Active substance
- Apomorphini hydrochloridum hemihydricum
- Manufacturer
- Ever Neuro Pharma GmbH
- Country
- Poland (PL)
- ATC code
- N04BC07
- ATC class
- Apomorphine
- Defined daily dose
- 20 mg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991247898
- gtin05909991247904
- gtin05909991247911
- gtin05909991247928
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
226 interactions on record for apomorphine.
Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Apomorphine · interactions on record
226 records
- 41 severe
- 182 moderate
- 2 minor
- 1 info
Most severe, free to view
- PapaverineA03AD01severe
- AlosetronA03AE01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Apomorphine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBRITAJECTSTADA Arzneimittel AG, Bad Vilbel
- SwedenAPO-go för POD 5 mg/ml Infusionsvätska, lösning i cylinderampullSTADA Arzneimittel AG
- SpainAPO-GO PFS 5 mg/ml SOLUCION PARA PERFUSION EN JERINGA PRECARGADAStada Arzneimittel Ag
- NorwayApomorfin PharmSwedEvolan Pharma AB
- SwitzerlandAPO-go
- BelgiumAPO-GO-CARTRIDGE 5 mg/mlEG
- FinlandApomorphine StadaSTADA Arzneimittel AG
- United KingdomAPO-go 20mg/2ml solution for injection ampoulesBritannia Pharmaceuticals Ltd
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Apo-Go, Apo-Go Ampullen
- Belgium · Apo-Go ®-Cartridge, Apo-Go-Pen
- Bulgaria · Dacepton, Апо-Гo Пнс
- Cyprus · Apo-Go Pfs, Apo-Go Συσκευή Τύπου Πένασ
- Czechia · Britaject, Britaject Pen
- Germany · Apo-Go, Apo-Go Ampullen
- Denmark · Apo-Go Pen, Apo-Go Pod
- Estonia · Apo-Go, Dacepton
- Spain · Apo-Go, Apo-Go Pen
- Finland · Apogo Pen, Dacepton
- France · Apokinon, Apomorphine Biogaran
- United Kingdom (Northern Ireland) · Apo-Go Ampoules, Apo-Go Pen
- Greece · Apo-Go Pfs, Apo-Go Pod
- Croatia · Dacepton
- Hungary · Dacepton
- Ireland · Apo-Go Ampoules, Apo-Go Pen
- Italy · Apofin, Dacepton
- Lithuania · Britaject, Dacepton
- Luxembourg · Apo-Go Ampoules, Apo-Go Pen
- Latvia · Apo-Go, Apo-Go Pen
- Malta · Apo-Go Pen, Apo-Go Pfs
- Netherlands · Apo-Go, Apo-Go Ampullen
- Norway · Apomorfin Pharmswed, Britaject
- Portugal · Apo-Go, Apo-Go Pen
- Romania · Apo-Go
- Sweden · Apo-Go, Apo-Go För Pod
- Slovenia · Apo-Go, Dacepton
- Slovakia · Dacepton
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4fbe60a2-98e9-41ec-82d2-839a18099577 GET /v1/drugs/4fbe60a2-98e9-41ec-82d2-839a18099577?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "5 mg/ml",
"packaging": "05909991247898 ¦ Rp ¦ 112143\n1 fiol. 20 ml\n05909991247904 ¦ Rp ¦ 112144\n5 fiol. 20 ml\n05909991247911 ¦ Rp ¦ 112145\n10 fiol. 20 ml\n05909991247928 ¦ Rp ¦ 112146\n30 fiol. 20 ml",
"substance": "Apomorphini hydrochloridum hemihydricum 5 mg/ml",
"common_name": "Apomorphini hydrochloridum hemihydricum",
"pl_product_id": "100357851",
"pozwolenie_nr": "22789",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about apomorphine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.